Top Markets
#1 TENDIES TENDIES +87.01%
#2 Akedo Akedo +85.25%
#3 Verus Coin Verus Coin +61.29%
#4 Threshold Network Threshold Network +42.93%
#5 MultiversX MultiversX +30.17%
#6 Mubarak Mubarak +29.69%
#7 Cash Cat Cash Cat +28.00%
#8 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#9 OSK OSK +16.18%
#10 edgeX edgeX +15.65%
Coin of the day
TENDIES TENDIES
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Neovasc Inc. Neovasc Inc.

Neovasc Inc.

NVCN
Kedudukan dalam Saham #17840
Neovasc Inc. is a medical technology firm specializing in the design,... Neovasc Inc. is a medical technology firm specializing in the design, production, and global distribution of cardiovascular devices, particularly across European markets and beyond. Its primary offerings include the Tiara system, developed for the transcatheter treatment of mitral valve disease, and the Neovasc Reducer, used to address chronic, debilitating chest pain known as refractory angina. Established in 2000, the company, which maintains its headquarters in Richmond, Canada, was formerly named Medical Ventures Corp. before adopting its current identity, Neovasc Inc., in July 2008.
Harga Saham
$29.82
Disegerakkan terakhir: 2023-04-11
Modal Pasaran
$223.68M
Perubahan (1 hari)
1.21%
Perubahan (1 tahun)
0.00%
Negara
CA
Perdagangan Neovasc Inc. (NVCN)

Kategori

Healthcare
Pendapatan untuk Neovasc Inc. (NVCN)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Neovasc Inc., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Neovasc Inc. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -
US